1. Home
  2. BLRX vs PRZO Comparison

BLRX vs PRZO Comparison

Compare BLRX & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • PRZO
  • Stock Information
  • Founded
  • BLRX 2003
  • PRZO 2014
  • Country
  • BLRX Israel
  • PRZO Israel
  • Employees
  • BLRX N/A
  • PRZO N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • PRZO
  • Sector
  • BLRX Health Care
  • PRZO
  • Exchange
  • BLRX Nasdaq
  • PRZO Nasdaq
  • Market Cap
  • BLRX 17.3M
  • PRZO 15.1M
  • IPO Year
  • BLRX 2011
  • PRZO 2023
  • Fundamental
  • Price
  • BLRX $3.59
  • PRZO $1.17
  • Analyst Decision
  • BLRX Strong Buy
  • PRZO
  • Analyst Count
  • BLRX 2
  • PRZO 0
  • Target Price
  • BLRX $220.00
  • PRZO N/A
  • AVG Volume (30 Days)
  • BLRX 154.8K
  • PRZO 803.9K
  • Earning Date
  • BLRX 03-25-2025
  • PRZO 03-26-2025
  • Dividend Yield
  • BLRX N/A
  • PRZO N/A
  • EPS Growth
  • BLRX N/A
  • PRZO N/A
  • EPS
  • BLRX N/A
  • PRZO N/A
  • Revenue
  • BLRX $21,991,000.00
  • PRZO $558,382.00
  • Revenue This Year
  • BLRX N/A
  • PRZO N/A
  • Revenue Next Year
  • BLRX N/A
  • PRZO N/A
  • P/E Ratio
  • BLRX N/A
  • PRZO N/A
  • Revenue Growth
  • BLRX N/A
  • PRZO N/A
  • 52 Week Low
  • BLRX $3.20
  • PRZO $0.49
  • 52 Week High
  • BLRX $57.60
  • PRZO $3.16
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 36.94
  • PRZO 33.12
  • Support Level
  • BLRX $3.26
  • PRZO $1.12
  • Resistance Level
  • BLRX $4.17
  • PRZO $1.49
  • Average True Range (ATR)
  • BLRX 0.28
  • PRZO 0.13
  • MACD
  • BLRX 0.24
  • PRZO -0.05
  • Stochastic Oscillator
  • BLRX 36.26
  • PRZO 6.94

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

Share on Social Networks: